Fudio, S
12  Ergebnisse:
Personensuche X
?
2

Development and validation of a liquid chromatography-tande..:

van Andel, L. ; Rosing, H. ; Lubomirov, R....
Journal of Pharmaceutical and Biomedical Analysis.  158 (2018)  - p. 160-165 , 2018
 
?
3

Metabolite profiling of the novel anti-cancer agent, plitid..:

van Andel, L. ; Rosing, H. ; Tibben, M. M....
Cancer Chemotherapy and Pharmacology.  82 (2018)  3 - p. 441-455 , 2018
 
?
4

Liquid chromatography-tandem mass spectrometry assay to qua..:

van Andel, L. ; Rosing, H. ; Fudio, S....
Journal of Pharmaceutical and Biomedical Analysis.  145 (2017)  - p. 137-143 , 2017
 
?
5

Pharmacokinetics and excretion of 14C–Plitidepsin in patien..:

van Andel, L. ; Fudio, S. ; Rosing, H....
Investigational New Drugs.  35 (2017)  5 - p. 589-598 , 2017
 
?
 
?
7

A Pharmacovigilance Program From Laboratory Signals for the..:

Ramirez, E ; Carcas, A J ; Borobia, A M...
Clinical Pharmacology & Therapeutics.  87 (2009)  1 - p. 74-86 , 2009
 
?
8

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, JF ; Landete, P ; Lopez-Martin, JA...
https://discovery.ucl.ac.uk/id/eprint/10142189/1/Thorne_e202101200.full.pdf.  , 2022
 
1-12